Corrigendum: Engineering and optimising deaminase fusions for genome editing
- PMID: 28991237
- PMCID: PMC5635175
- DOI: 10.1038/ncomms16169
Corrigendum: Engineering and optimising deaminase fusions for genome editing
Abstract
This corrects the article DOI: 10.1038/ncomms13330.
Erratum for
-
Engineering and optimising deaminase fusions for genome editing.Nat Commun. 2016 Nov 2;7:13330. doi: 10.1038/ncomms13330. Nat Commun. 2016. PMID: 27804970 Free PMC article.
Similar articles
-
Engineering and optimising deaminase fusions for genome editing.Nat Commun. 2016 Nov 2;7:13330. doi: 10.1038/ncomms13330. Nat Commun. 2016. PMID: 27804970 Free PMC article.
-
Corrigendum: In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.Nat Biotechnol. 2017 Dec 8;35(12):1211. doi: 10.1038/nbt1217-1211a. Nat Biotechnol. 2017. PMID: 29220013
-
Corrigendum to "Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies": [Immuno-Oncology and Technology 10 (2023) 100394].Immunooncol Technol. 2023 Oct 17;20:100410. doi: 10.1016/j.iotech.2023.100410. eCollection 2023 Dec. Immunooncol Technol. 2023. PMID: 37886680 Free PMC article.
-
Applications of genome editing by programmable nucleases to the metabolic engineering of secondary metabolites.J Biotechnol. 2017 Jan 10;241:50-60. doi: 10.1016/j.jbiotec.2016.11.009. Epub 2016 Nov 11. J Biotechnol. 2017. PMID: 27845165 Review.
-
Germline genome-editing research and its socioethical implications.Trends Mol Med. 2015 Aug;21(8):473-81. doi: 10.1016/j.molmed.2015.05.006. Epub 2015 Jun 12. Trends Mol Med. 2015. PMID: 26078206 Review.
Cited by
-
Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects.Curr Gene Ther. 2024;24(5):377-394. doi: 10.2174/0115665232279528240115075352. Curr Gene Ther. 2024. PMID: 38258771 Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources